N=1 After 40

Daily routine ledger

Daily Stack Change Log

A dated record of what entered, left, moved, or changed in the routine. The main Daily Stack page remains the current snapshot.

September 2026

  • Anavar (oxandrolone) Added Anavar from a gray-market source on workout days only, split into 15 mg after waking and 10 mg before sleep (25 mg total), to preserve muscle and maintain training performance during the cut. A potential fat-mass effect is an additional reason for the experiment, without treating Anavar as a powerful thermogenic.
  • Cardarine (GW-501516) Added 15 mg every morning while fasted for a new blood-lipid experiment focused on ApoB, LDL cholesterol, HDL cholesterol, and triglycerides. The earlier no-signal result for endurance, training feel, and recovery remains unchanged.
  • CL-316243 Added 5 mg every morning while fasted to revisit the helpful visual fat-loss result from the earlier run and see whether the stronger response during the first two weeks repeats.
  • L-carnitine Added 1,000 mg every other day post-workout to test whether supporting mitochondrial fatty-acid transport helps maintain energy and training output alongside ATX-304, SANA, and BAM15.
  • Glycine Added 6 g daily just after waking to support glutathione production, collagen synthesis, and connective tissue health. The existing 3 g before sleep continues, bringing the daily total to 9 g.
  • SANA (MVD1) Increased from 200 mg/day after waking to 400 mg/day, split into 200 mg after waking and 200 mg before sleep, to pursue greater benefit through continued titration.
  • SLU-PP-915 Increased from 10 mg to 20 mg after waking to pursue greater benefit through continued titration.
  • BAM15 Increased from 200 mg/day to 1,500 mg/day, split into 500 mg post-workout, 500 mg after the daily large meal, and 500 mg before sleep, to pursue greater benefit. The first dose moved from after waking to post-workout to prevent low energy during training.
  • ATX-304 Added 400 mg/day, split into 200 mg after waking and 200 mg before sleep, to test whether the current exposure produces a meaningful change in body composition or metabolic markers while tracking exercise energy and recovery.
  • DIM Added 300 mg after the daily large meal for improved estrogen management.
  • NP Thyroid Changed the displayed source from the product name to Prescribed to reflect that it is prescribed medication.
  • Ezetimibe Changed the displayed source from the supplier name to Prescribed to reflect that it is prescribed medication.

August 2026

  • Modafiendz Changed the schedule from daily to occasionally to reflect actual use rather than treating Modafiendz as part of the fixed daily routine.
  • N-Acetylcysteine (NAC) Added 1 g/day just after waking to support endogenous glutathione production and antioxidant capacity as an additional general liver-support measure.
  • BAM15 Started a fat-loss experiment at 200 mg/day, split into 100 mg after waking and 100 mg before sleep, to observe its effect on weight trend, body composition, temperature, resting heart rate, training performance, and recovery. A possible additional 100 mg midday dose will be considered later and, if added, recorded as a separate phase.
  • NP Thyroid Added prescribed desiccated thyroid at 15 mg daily as a tracked experiment to see whether it produces a repeatable change in daily energy or the rate of weight loss. It is taken alone during the usual overnight wake-up, at least four hours after the bedtime stack, to preserve a consistent fasting window without delaying the morning training routine.
  • Rauwolscine Removed Rauwolscine from Before Sleep and paused the experiment because the evening six-capsule Cyclean AM exposure produced a thermogenic response that was too strong, left me feeling cold, and made sleep difficult. I may revisit it in a different time slot.
  • SANA (MVD1) Increased from 100 mg/day to 200 mg/day pre-workout because 100 mg produced little noticeable thermogenic effect.
  • SLU-PP-332 Removed from Pre-Workout after twelve 500 mcg subcutaneous administrations between August 6 and August 19, totaling 6 mg. The first two exposures raised heart rate by about 10% at the same perceived cardio effort, but the response disappeared and no meaningful lifting effect or repeatable training benefit followed, so the experiment was closed as no signal.
  • SLU-PP-915 Added after waking at 10 mg/day to test whether it produces a repeatable improvement in exercise energy and training capacity, with potential weight loss as a secondary outcome.
  • Rauwolscine Started a one-month rauwolscine experiment at 3 mg/day, delivered by 6 Cyclean AM capsules immediately before the daily one-hour evening walk, to test that target exposure for thermogenesis and weight or fat loss in a consistent activity window while leaving the wake-up slot open for a separate experiment.
  • Gorilla Mode Replaced Transparent Labs Bulk Black with 2 scoops of Gorilla Mode every day, including cardio and rest days, to use one comprehensive pre-workout consistently across the full rotation.
  • Beta-alanine Replaced the two 1.6 g products with Gorilla Mind Beta-Alanine at 3.2 g after waking and 3.2 g before sleep, bringing the daily total to 6.4 g for a consistent performance-focused dose.
  • Creatine monohydrate Rebuilt the daily 15 g total as 5 g from Gorilla Mode, 5 g with the intra-workout routine, and 5 g with whey after the workout-time anchor; standalone servings now use Gorilla Mind Creatine Monohydrate.
  • Essential amino acids Replaced Kion Aminos with 1 scoop of Gorilla Mode EAAs, providing 12 g daily, to consolidate the intra-workout routine under Gorilla Mind.
  • Whey protein Replaced Transparent Labs whey isolate with 1 scoop of Gorilla Whey, providing 25 g protein daily, to move the post-workout protein source to Gorilla Mind.
  • Transparent Labs Post Removed the blended post-workout product because its creatine and recovery role is now covered by Gorilla Mode, standalone creatine, whey, and the existing recovery stack.
  • HGH Increased from 6 IU to 8 IU every morning as the experiment continues to titrate upward.
  • SANA (MVD1) Increased from 50 mg/day to 100 mg/day because no noticeable effect has emerged at 50 mg so far.
  • Glutathione Removed the daily 250 mg compounded troche after completing the three-month detox cycle.
  • Ezetimibe Corrected the source from Prescription to TelyRx to reflect the actual supplier.
  • Inositol Added 2 g just after waking and 2 g before sleep to support cell-membrane and second-messenger signaling alongside the current peptide routine.
  • Taurine Increased from 3 g to 6 g; serving changed from 3 to 6 capsules because Transparent Labs Bulk removed taurine when its formula changed.
  • L-Citrulline Removed from Pre-Workout because Transparent Labs Bulk added it to its formula.
  • Pregnenolone Added after the daily large meal at 100 mg.
  • Psyllium husk Added before sleep at 5 g.
  • SANA (MVD1) Added to the wake-up stack at 50 mg/day.
  • CL-316243 Removed from Pre-Workout.
  • 5-HTP Removed from the after-meal stack because it might interfere with the Cerebrolysin experiment. It will return after that experiment is complete.
  • Retatrutide Increased from 6 mg/week to 9 mg/week by adding a third 3 mg injection on August 12. The ongoing schedule is 3 mg Monday, Wednesday, and Friday, increased to test whether the higher weekly exposure produces a greater fat-loss benefit.
  • SLU-PP-332 Added to Pre-Workout at 500 mcg/day.
  • Vitamin C Added Post Workout at 500 mg, primarily to improve collagen uptake.
  • Ezetimibe Added after the daily large meal at 10 mg/day as a temporary workaround while looking for a solution for genetically elevated Lp(a).
  • HCG Increased from 200 IU to 250 IU per scheduled day.
  • HGH Increased from 4 IU to 6 IU every morning.
  • L-Citrulline Added to Pre-Workout at 3 g.
  • Testosterone CYP Changed to 210 mg/week, logged as 70 mg three days per week.
  • Nandrolone decanoate Increased from 60 mg/week to 100 mg/week.
  • Retatrutide Increased from 4 mg/week to 6 mg/week, split between Tuesday and Friday.
  • MOTS-c Removed from Compounds when the experiment was completed.

July 2026

  • HGH Increased from 3 IU to 4 IU every morning.
  • Nicotinic acid Removed from the after-meal stack when the experiment was completed.
  • Nandrolone decanoate Added to Compounds at 60 mg/week.
  • AOD-9604 Removed from the wake-up stack when the experiment was completed.
  • Glycine Added before sleep at 3 g.
  • HGH Added to the wake-up stack at 3 IU every morning.
  • CL-316243 Replaced pre-workout Tesamorelin at 7.5 mg on training days.
  • TUDCA Added after the daily large meal at 500 mg.
  • Modafiendz Added after the daily large meal at 50 mg.
  • Maltodextrin Removed from During Workout because fasted training is working well.
  • MOTS-c Increased from 3 mg/week to 9 mg/week across three scheduled injections.
  • Beta-alanine Standardized the wake-up and after-meal entries at 1.6 g.
  • Bromantane, NAD+ and AOD-9604 Moved into the wake-up stack.
  • Tesamorelin Moved from Compounds into Pre-Workout at 1 mg and Before Sleep at 2 mg.
  • BPC-157, KPV, GHK-Cu and TB-500 Moved from Compounds into Post Workout with updated logged amounts.
  • Green tea extract, SS-31 and post-workout creatine Removed from the current stack.
  • MOTS-c Added to Compounds at 3 mg/week.

June 2026

  • PQQ and Ubiquinol Added after the daily large meal at 20 mg and 100 mg respectively to support upcoming mitochondrial peptide experiments.
  • Cardarine Removed from the wake-up stack when the experiment was closed.
  • Bromantane Added to Compounds at 50 mg/day.
  • Cardarine Increased from 10 mg to 20 mg/day.
  • Maltodextrin Removed from Post Workout.
  • Tesamorelin Increased from 2 mg to 3 mg on workout days.
  • SS-31 Increased from 4 mg/day to 5 mg/day.
  • Pinealon Removed from Compounds because the experiment cycle was complete.
  • During-workout carbohydrate Changed from highly branched cyclic dextrin to maltodextrin.
  • Retatrutide Increased from 2.4 mg/week to 4 mg/week, split between Tuesday and Friday.
  • Tadalafil Removed from the wake-up stack because the experiment failed.
  • Tesamorelin Added to Compounds at 2 mg on workout days.
  • SS-31 Added to Compounds at 4 mg/day.
  • Retatrutide Added to Compounds at 2.4 mg/week.
  • Epicatechin Removed from the wake-up stack when the experiment was completed.
  • Nicotinic acid Renamed from Niacin Vitamin B3 as its experiment record began.
  • Beta-alanine Moved from Before Sleep to After Daily Large Meal.
  • AOD-9604 and Pinealon Added to Compounds at 300 mcg/day each.
  • KPV Added to the workout-day compound group at 300 mcg.
  • BPC-157, GHK-Cu and TB-500 Source changed from Compounded to Gray Market.
  • Daily Stack Published with wake-up, pre-workout, during-workout, post-workout, after-meal, before-sleep and compound sections.